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Introduction
Numerous studies describe the age-related decline in 
skeletal muscle mass and strength1,2. As the European 
Working Group on Sarcopenia in Older People (EWGSOP) 
stated in their revised European consensus on the definition 
of sarcopenia, sarcopenia is not only defined as a reduction 
in muscle mass and muscle strength with increasing age, but 
also with low physical performance3. The concept of physical 
performance includes multidimensional, neuromuscular 
functions during movement. Therefore, muscle power is 
a crucial parameter of physical performance because it is 
defined as the product of force and velocity and is derived 
from how quickly and powerfully the body can move4. Muscle 
power has been recently discussed as playing an important 
role in predicting immobilisation, the risk of falls, and 
sarcopenia5-7. Various studies on the relationship of muscle 
and age emphasise the role of muscle power, as it decreases 
earlier over the lifespan and to a greater extent than muscle 
mass or strength, and has greater association with functional 
status and impairments in functional daily activities than other 
muscle parameters1,7-11. Further, numerous studies reported 
that the loss of muscle strength and mass over time is greater 
in longitudinal studies than in cross-sectional studies, which 
remains to be investigated for muscle power12-17. In addition, 
longitudinal studies showed a relationship between muscle 
power and clinical parameters such as frailty or mobility 
decline in older adults18,19. Therefore, a longitudinal study 
design appears more appropriate than a cross-sectional 
design for examining the development and deterioration 
process of muscle power over age.
A suitable instrument for measuring muscle power over a 
wide range of ages is muscle mechanography. Computerised 
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force platforms record the movements of the centre of 
gravity and the applied force vectors during locomotor tasks 
like two-leg jumps or a chair rise test4. Integrated software 
calculates muscle function parameters, such as force, velocity 
or power4. Reproducibility and excellent retest reliability 
have been confirmed for jumping mechanography20-22 
and moderate reliability has been reported for the chair 
rise test20,21,23. Muscle mechanography is also considered 
to be a safe assessment instrument4,20,22,24,25 with a high 
acceptability25 even in older populations. Age-related and 
sex-related reference values for muscle power measured 
by muscle mechanography have been published for use in 
diagnostics and therapy26-29.
The EWGSOP identified the need to provide parameters 
and assessment instruments to detect sarcopenia more 
effectively and predict health related outcomes as being a 
gap in the research3. In addition, data on body composition 
shows strong regional and ethnic differences and such data 
is not sufficiently available from Germany30. Therefore, 
the purpose of this longitudinal study is to examine and to 
compare the changes over time in body composition, muscle 
strength and muscle power in a randomly selected sample 
of 20 to 90-year-old subjects in Berlin, Germany. This 
is the first study to provide longitudinal data for jumping 
mechanography and the chair rise test with Leonardo 
Mechanograph®. The results of this study should contribute 
to a better recognition and quantification of diseases in 
connection with body composition and functional muscle 




The data of the present study was collected as part of 
the German project “muscle survey 2”. This is the six-
year follow-up of a population-based, cross-sectional 
study focussing on muscle and bone health. The subjects 
recruited for the baseline evaluation were randomly-
selected and age- and sex-stratified from the resident 
registration office in Berlin, Germany. The exclusion criteria 
for both evaluations were: 1) metal implants or artificial 
prostheses; 2) oedema; 3) medication affecting water-
mineral homeostasis; 4) a walking aid; 5) contraindications 
for X-ray exposure; 6) pregnancy; 7) cognitive impairment 
that prevented informed consent26,31. Details regarding the 
recruitment process, screening criteria and results of the 
baseline muscle survey were provided elsewhere26,31.
All examinations were performed at the Centre for 
Muscle and Bone Research at Charité-Universitätsmedizin 
Berlin. The study design and procedures were approved 
by the ethics committee of Charité-Universitätsmedizin 
Berlin (EA4/021/14; EA4/095/05) and by the German 
Radiation Protection Ordinance (Z5-22462/2-2005-063; 
Z5-22462/2-2014-025). Written informed consent was 
obtained from all participants. 
The subjects of the baseline examination were contacted 
via postal letters again and asked to return for a follow-up 
examination. If the invitation letter was sent back due to 
the address of the participant being unknown, an extensive 
search at the resident registration office in Berlin was 
conducted to find out the new address or whether the person 
had died. Subjects who did not respond received a second 
invitation letter after 6 months. 
For the current study, data of the participants who attended 
both investigations were used. Depending on the assessment 
instrument and the test, different numbers of data sets could 
be analysed, i.e. different n. This was caused, for example, 
by technical errors, test failures or exclusion due to extreme 
values. Some subjects were also not able to perform all tests 
due to medical conditions. 
Anthropometry
Body weight and body height were measured to the 
nearest 0.1 kg and 0.1 cm, using an electronic measuring 
and weighing station (Seca 764). Body mass index (BMI) was 
calculated as weight (kg) divided by height squared (m2).
Assessment of muscle power
The muscle power assessment was performed on the 
Leonardo Mechanograph® Ground Reaction Force Plate 
(Novotec Medical GmbH, Pforzheim, Germany software 
package 4.2). Sampling frequency was 800 Hz. The examiner 
showed and explained all tests in advance, but according to 
the protocol the participants were not allowed to practice the 
tests. The tests were performed with the participants’ own 
comfortable flat shoes and clothes. The same test order was 
used at baseline and follow-up.
Jumping mechanography
First, the participants performed three two-leg jumps 
(2LJ) as a countermovement jump on the platform. They were 
asked to jump as high as possible “to reach the bananas”. 
They were allowed to move their arms freely. There was a 
one-minute break between each jump. The jump with the 
highest jumping power was selected for further analysis. The 
main measurement outcome variable was the maximum total 
relative power per body weight in W/kg during lift off (2LJP).
Chair Rise Test (CRT)
Following the jumping mechanography, the chair rise test 
was performed. A bench with a height of 45 cm was anchored 
in the Leonardo force plate. During the CRT, the participants 
were asked to move 5 times, as quickly as possible, from a 
seated to standing position. They kept their arms crossed 
in front of their chest. The test was performed only once. 
CRT assesses the hip surrounding muscle function which 
is essential for preventing fall-related injuries11. The main 
measurement outcome variable was the maximum total 
relative power per body weight in W/kg during the rise phases 
(CRTP).
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Assessment of muscle strength
Finally, hand grip strength was assessed using a hand 
dynamometer (Takei Scientific Instruments Co. Ltd., 
Tokyo, Japan). The subject was standing upright, and the 
arms were hanging down at the side of their body. The test 
person was asked to squeeze the dynamometer as tightly 
as possible. Their arm remained in an extended position. 
Both hands were measured three times each and the 
highest value out of six trials was used for analysis. As 
Figure 1. Flowchart. 
Table 1. Dropout comparison of baseline characteristics. 
 
Women Men
Dropout  Follow-up  Dropout  Follow-up
n 214 170 234 148
Age (years) 52.6±20.9 54.7±14.0 51.1±20.6 57.6±15.2**
Weight (kg) 67.7±11.8 68.1±10.8 81.1±12.9 83.7±11.6*
Height (cm) 164.5±7.0 163.8±6.7 176.3±8.0 176.3±6.8
BMI (kg/m2) 25.1±4.4  25.4±4.0 26.11±3.8 26.9±3.4*
Data is mean ± SD. Dropouts did not return for the follow-up. ** Significant differences between dropouts and follow-ups for p<0.001 
evaluated by unpaired t-test. * Significant differences between dropouts and follow-ups for p<0.05 evaluated by unpaired t-test.
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a variable of interest, the “maximum grip strength” was 
used as recommended by standardised approaches32 and 
recorded to the nearest 0.1 kg.
Assessment of body composition
Body composition was evaluated by dual-energy X-ray 
absorptiometry (DXA). Measurements were conducted by 
Lunar Prodigy Advance, GE Healthcare (Software enCORE 
v13.6) or Lunar iDXA, GE Healthcare (Software enCORE 
v13.6).
Initially, the investigation began with the Prodigy device. 
The enhanced Lunar iDXA was used later during the 
baseline investigation. All participants of the follow-up were 
measured with the same device that they had used during the 
baseline survey (n=44 prodigy and n=274 iDXA). Therefore, 
the longitudinal changes do not depend on the distinction 
between the two devices. 
Lean mass in the arms and legs in kg were used as indicators 
of muscle quantity, i.e. muscle mass, and thus integrated into 
the analysis. To obtain an estimate of appendicular skeletal 
muscle mass (ASM) the sum of the muscle mass of the arms 
and legs was used, as Baumgartner et al. suggested33. Due 
to the correlation between muscle mass and body size, there 
are different possibilities of adjustment: we integrated the 
appendicular skeletal muscle mass to height ratio (ASM/
height2 in kg/m2) and to body mass index (ASM/BMI in m2) 
into the analysis3.
Statistical analysis
Descriptive statistics and the comparison of baseline 
anthropometric characteristics are presented as mean ± 
standard deviation (SD). Differences between dropouts and 
subjects returning for testing at the follow-up were evaluated 
by unpaired students’ t-test. 
Changes in body composition, muscle strength and 
muscle power over time were tested using paired t-tests 
by age group (20-39, 40-49, 50-59, 60-69, and over 70 
years at baseline) and sex, and are reported as the absolute 
change with the mean ± standard deviation. To analyse the 
variation of all variables between subjects of an age group, 
the coefficient of variation in percentages (CV%) is reported 
for the absolute change. It was calculated from the SD divided 
by the mean of variable x multiplicated by 100. To determine 
the effect size, Cohen’s d was computed. 
Absolute annual change in each measure was calculated 
as follow-up value minus baseline value divided by follow-
up time.
The annual change is expressed as a percentage and 
determined in the following way: 
×100
absolute change value
baseline value × time between t1 and t2
Two-way analysis of variance (ANOVA) was used to assess 
the absolute and percentage annual change by age group 
and sex. Because the age group*sex interaction term was 
never significant, only main effects were studied. Results are 
presented as mean ± standard deviation. Differences between 
subject groups were determined with Dunnett’s tests using 
the youngest age group (20-39 years) as a reference group. 
The mean annual change (%) of each age group of 2LJP 
was compared with the mean of the same age group of CRTP, 
all variables of body composition and grip strength using one 
sample t-tests. Men and women were compared separately. 
Statistical significance was set at p<0.05 for all analyses. 
All statistical analyses were performed with SPSS, software 
package version 25.
Results
318 subjects were integrated in the follow-up analysis. 
The average follow-up interval was 6.1±0.9 years. Of the 
original cohort (n=766), 46.5% returned for testing, 4.7% 
died (n=36), 4.3% moved away (n=33), 3.1% were not found 
(n=24) and 16.2% did not respond (n=124). 25.2% refused 
testing (n=193). Reasons for refusal included health problems 
(34.2%), lack of interest (15.4%), lack of time (27.5%) and 
other reasons (21.8%) (Figure 1). The lowest rates of return 
were in the youngest and oldest age groups, with 15.6% 
and 24.6%, respectively. Figure 1 shows a flowchart of the 
retention process of the study population. 
Subject characteristics from the baseline evaluation 
are presented in Table 1. The mean age for follow-up was 
54.7±14.0 years for females and 57.6±15.2 years for males. 
A comparison of baseline characteristics indicates that 
women who returned for testing were similar in their baseline 
age, weight, height and BMI to those who had dropped out. 
The males returned for testing were significantly older 
(p<0.01) and had significantly higher weight and BMI, with 
both p<0.05, than those who had dropped out.
Tables 2 and 3 show the longitudinal changes in muscle 
mass, muscle strength and muscle power by age group in 
women (2) and men (3). 
Absolute longitudinal change of muscle power, strength 
and mass
CRTP and 2LJP decreased for both sexes from the age 
group 20-39 years. This absolute change is distinctly 
significant in all age groups for women (p<0.001), and also 
for men (p<0.001), except for the youngest age group of men 
for CRTP (p=0.192) (Tables 2, 3).
The highest annualized absolute decline can be seen in 
the oldest age group of 2LJP with -0.88 W/kg for women 
and -0.99 W/kg for men. The youngest age group shows an 
annual decline of -0.46 W/kg and -0.75 W/kg, respectively 
(Tables 2, 3). As Figure 2 shows, the evolution of 2LJP was 
quite variable at any age. 
Maximum grip strength shows significant losses by the 
age of 70+ years in men (p<0.001) (Table 3). In women the 
decrease is noted significantly earlier from the age of 50 
years (p=0.001) (Table 2). 
A significant decrease of ASM/BMI can be seen in all age 
groups and for both sexes (p=0.001-0.039). For ASM/h2, a 
significant absolute decline can be observed in women and 
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Table 2. Changes by age group during the follow-up period in women.
Age 
group













mean±SD mean±SD CV (%) mean±SD mean±SD
Lean mass 
arms (kg) 
20-39 28 4.21±0.60 0.13±0.28 215.4 0.022 0.5 0.02±0.04 0.37±0.87
40-49 37 4.30±0.45 0.06±0.24 400.0 0.136 0.3 0.01±0.04 0.29±1.04
50-59 40 4.10±0.64 -0.02±0.26 1452.1 0.647 0.1 -0.003±0.05 -0.05±1.13
60-69 35 4.19±0.61 -0.14±0.24 165.0 0.002 0.6 -0.02±0.04* -0.54±1.00**
70+ 30 4.08±0.54 -0.15±0.60 400.0 0.181 0.3 -0.03±0.09* -0.55±2.33**
Lean mass 
legs (kg)
20-39 28 14.26±1.99 0.24±0.84 350.0 0.139 0.3 0.03±0.11 0.19±0.72
40-49 37 14.18±1.68 -0.14±0.65 467.7 0.195 0.2 -0.03±0.12 -0.17±0.85
50-59 40 13.26±2.05 -0.32±0.76 239.6 0.013 0.4 -0.05±0.13* -0.38±0.93**
60-69 35 13.10±1.93 -0.44±0.65 147.7 0.000 0.7 -0.08±0.11** -0.53±0.88**
70+ 30 12.74±1.35 -0.31±0.56 180.6 0.005 0.6 -0.05±0.09* -0.37±0.71**
ASM/h2 
(kg/m2)
20-39 28 6.57±0.81 0.13±0.36 276.9 0.066 0.4 0.02±0.05 0.23±0.68
40-49 37 6.69±0.64 0.03±0.28 860.1 0.527 0.1 -0.01±0.05 -0.07±0.78
50-59 40 6.48±0.82 -0.12±0.34 283.3 0.028 0.4 -0.02±0.06* -0.31±0.88**
60-69 35 6.65±0.77 -0.21±0.30 144.3 0.000 0.7 -0.04±0.05*** -0.54±0.80**
70+ 30 6.52±0.68 -0.18±0.34 188.9 0.008 0.5 -0.03±0.05** -0.42±0.81**
ASM/BMI 
(m2)
20-39 28 0.75±0.12 -0.02±0.04 200.0 0.039 0.5 -0.002±0.006 -0.27±0.81
40-49 37 0.72±0.11 -0.02±0.03 150.0 0.000 0.7 -0.005±0.006 -0.66±0.85
50-59 40 0.69±0.08 -0.02±0.03 150.0 0.000 0.7 -0.004±0.005 -0.48±0.73
60-69 35 0.65±0.07 -0.01±0.04 400.0 0.029 0.3 -0.002±0.006 -0.31±0.87






20-39 28 31.53±5.35 -0.19±3.32 1747.4 0.761 0.1 -0.01±0.42 0.06±1.32
40-49 37 29.65±3.29 0.52±2.22 426.3 0.160 0.2 0.10±0.40 0.34±1.43
50-59 40 28.93±4.61 -1.36±2.38 175.0 0.001 0.6 -0.24±0.41 -0.79±1.37
60-69 35 28.11±3.60 -1.12±2.57 229.5 0.015 0.4 -0.19±0.45 -0.61±1.61




20-39 28 12.37±2.24 -0.62±1.57 253.2 0.046 0.4 -0.09±0.24 -0.58±1.76
40-49 37 12.23±1.96 -1.14±1.16 101.3 0.000 1.0 -0.21±0.21 -1.73±1.85
50-59 39 10.90±1.74 -0.89±1.24 139.8 0.000 0.7 -0.16±0.22 -1.42±1.99
60-69 35 10.07±1.44 -0.99±1.19 120.6 0.000 0.8 -0.17±0.20 -1.59±2.07
70+ 28 9.02±1.61 -1.00±0.97 97.0 0.000 1.0 -0.17±0.17 -1.84±1.82*
2LJP 
(W/kg)
20-39 28 37.41±5.61 -3.70±2.80 75.7 0.000 1.3 -0.46±0.34 -1.22±0.86
40-49 37 34.02±5.13 -2.99±3.07 102.7 0.000 1.0 -0.55±0.56 -1.64±1.78
50-59 39 31.68±5.63 -3.93±2.78 70.8 0.000 1.4 -0.69±0.48 -2.13±1.34*
60-69 34 28.52±4.65 -4.53±2.62 57.8 0.000 1.7 -0.78±0.45* -2.68±1.37***
70+ 26 24.37±4.46 -5.24±2.10 40.1 0.000 2.5 -0.88±0.34** -3.50±1.20***
Notes. Data are means ± SD. CV%= coefficient of variation in %. Absolute change= follow-up value - baseline value. Absolute annual 
change= absolute change/follow-up period. P-value of paired t-test changes from Baseline, bold values = significant p<0.05. Annual change 
(%) = ((follow-up value - baseline value)/(baseline-value * follow-up period))*100. *significant differences compared to the youngest adults 
(20-39 years) (p<0.05). **significant differences compared to the youngest adults (20-39 years) (p<0.01). ***significant differences 
compared to the youngest adults (20-39 years) (p<0.001).
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mean±SD mean±SD CV (%) mean±SD mean±SD
Lean mass 
arms (kg) 
20-39 25 7.57±1.23 -0.07±0.36 514.3 0.322 0.2 -0.01±0.05 -0.12±0.59
40-49 17 7.67±1.41 -0.11±0.45 424.1 0.345 0.2 -0.02±0.08 -0.16±1.07
50-59 36 7.07±0.95 -0.28±0.52 185.7 0.003 0.5 -0.05±0.09 -0.67±1.27
60-69 37 6.72±0.91 -0.32±0.39 121.9 0.000 0.8 -0.06±0.07 -0.78±1.02
70+ 33 6.55±0.84 -0.48±0.44 91.7 0.000 1.1 -0.08±0.07** -1.19±1.07***
Lean mass 
legs (kg)
20-39 25 20.78±2.45 -0.06±0.90 1500.0 0.738 0.1 -0.01±0.12 -0.05±0.59
40-49 17 21.02±2.99 -0.10±0.87 828.9 0.626 0.1 -0.02±0.16 -0.06±0.73
50-59 36 19.12±1.87 -0.35±1.13 322.9 0.071 0.3 -0.06±0.20 -0.33±1.07
60-69 37 17.63±2.61 -0.53±0.90 169.8 0.001 0.6 -0.09±0.16 -0.46±0.86
70+ 33 18.12±2.13 -0.51±1.21 237.3 0.022 0.4 -0.08±0.19 -0.43±1.06
ASM/h2 
(kg/m2)
20-39 25 8.71±0.98 -0.04±0.35 882.0 0.536 0.1 -0.01±0.05 -0.08±0.53
40-49 17 8.63±1.07 -0.07±0.38 547.7 0.456 0.2 -0.01±0.07 -0.10±0.76
50-59 36 8.26±0.73 -0.20±0.48 240.0 0.019 0.4 -0.04±0.09 -0.42±1.04
60-69 37 8.18±0.86 -0.28±0.38 135.7 0.000 0.7 -0.05±0.07 -0.55±0.82
70+ 33 8.24±0.82 -0.33±0.53 160.6 0.001 0.6 -0.05±0.08 -0.63±0.10
ASM/BMI 
(m2)
20-39 25 1.06±0.11 -0.05±0.07 140.0 0.001 0.7 -0.006±0.009 -0.55±0.84
40-49 17 1.06±0.08 -0.03±0.05 166.7 0.023 0.6 -0.005±0.008 -0.47±0.77
50-59 36 0.98±0.10 -0.05±0.05 100.0 0.000 1.0 -0.009±0.008 -0.87±0.83
60-69 37 0.88±0.11 -0.02±0.03 150.0 0.000 0.7 -0.004±0.005 -0.40±0.59






20-39 25 46.83±6.14 0.29±5.50 1896.6 0.796 0.1 0.02±0.71 0.15±1.54
40-49 17 48.70±4.17 -0.98±2.89 294.9 0.181 0.3 -0.18±0.54 -0.35±1.10
50-59 36 45.82±7.51 0.29±5.08 1752.2 0.733 0.1 0.04±0.89 0.25±2.32
60-69 37 43.47±7.60 -1.71±5.42 317.0 0.063 0.3 -0.29±0.94 -0.38±2.72




20-39 25 14.74±2.43 -0.59±2.21 374.6 0.192 0.3 -0.08±0.27 -0.32±1.96
40-49 17 15.67±1.99 -1.62±1.20 74.1 0.000 1.4 -0.30±0.22* -1.84±1.36
50-59 35 13.89±1.86 -1.68±2.02 120.7 0.000 0.8 -0.30±0.37** -2.13±2.70**
60-69 37 12.29±1.95 -1.71±1.19 69.7 0.000 1.4 -0.30±0.20* -2.46±1.63**
70+ 32 10.91±2.13 -1.93±2.06 107.0 0.000 0.9 -0.31±0.31** -2.76±2.88***
2LJP 
(W/kg)
20-39 25 49.25±6.59 -5.97±3.90 65.3 0.000 1.5 -0.75±0.46 -1.51±0.86
40-49 17 45.03±4.52 -3.96±3.68 92.9 0.000 1.1 -0.73±0.67 -1.59±1.39
50-59 36 38.94±6.08 -3.94±3.47 88.1 0.000 1.1 -0.72±0.64 -1.78±1.56
60-69 37 35.17±5.89 -4.54±3.50 77.0 0.000 1.3 -0.78±0.59 -2.18±1.61
70+ 30 28.87±5.00 -6.20±4.12 66.4 0.000 1.5 -0.99±0.65 -3.34±1.90***
Notes. Data are means ± SD. CV%= coefficient of variation in %.  Absolute change= follow-up value - baseline value. Absolute annual 
change= absolute change/follow-up period. P-value of paired t-test changes from Baseline, bold values = significant p<0.05. Annual change 
(%) = ((follow-up value - baseline value)/(baseline-value * follow-up period))*100. *significant differences compared to the youngest adults 
(20-39 years) (p<0.05). **significant differences compared to the youngest adults (20-39 years) (p<0.01). ***significant differences 
compared to the youngest adults (20-39 years) (p<0.001).
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men in the age groups 50-59 (p=0.028 vs. 0.019), 60-69 (both p<0.001) and over 
70 years (p=0.008 vs. 0.001) (Table 2, 3).
The absolute annual change of variables of strength and mass shows a highly 
variable trend over age and sex (Figure 2).
Annual percentage change of muscle power compared to strength and mass
Figures 3a and 3b present the mean annual changes in percentages. In both sexes, 
a pronounced annual decline of muscle power in CRT and 2LJ is evident in all age 
groups, beginning in the 20-39 years of age group (Figure 3a, b). The decline of 2LJP 
in this age group is much more pronounced and begins significant earlier compared 
to CRTP, muscle strength and mass in both sexes (-1.22% per year in females, -1.51% 
per year in males, p<0.001). The most obvious decrease in women is visible for 2LJP 
at the ages of 70 years and older (-3.5% per year). This is significantly different to 
all other variables (p<0.001 and p<0.01 for CRTP) in the same age group. In men, 
the oldest age group of 2LJP (-3.34% per year) is significantly different compared 
to all other variables in the same age group (p<0.001), except for CRTP (p=0.102). A 
significant difference between 2LJP and CRTP in men is only visible in the youngest 
age group (p<0.001).
Figure 2. Individual absolute annual change in 2LJP, CRTP, grip strength, ASM/BMI and ASM/h2 according to age and sex.
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Figure 3a, b. Annual percentage change in females (a) and males (b). Values of p, one sample t-test between the mean of each age group 
of 2LJP with the same age group of each other variable: *** significant difference with p<0.001, compared to the same age group of 
2LJP, ** significant difference with p<0.01 compared to the same age group of 2LJP.
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Discussion
The present study showed the longitudinal changes in body 
composition, muscle strength and muscle power measured 
by DXA, hand dynamometer and muscle mechanography 
in a healthy sample of Berlin inhabitants aged between 20 
and 90 years. This is the first study to report longitudinal 
age- and sex-related data on muscle power measured by 
Leonardo Mechanograph®. Findings of this analysis underline 
the importance of the assessment of muscle power in the 
clinical diagnosis of sarcopenia.
One of the most obvious results of this study is the early 
age-related decline of muscle power assessed by 2LJ 
compared to CRTP, muscle mass and strength. Relative power 
of 2LJ seems to be an important indicator of the beginning 
of deterioration processes. Whereby the decline in 2LJP 
becomes apparent even earlier at the age of 20-39 years 
than in CRTP, which shows at the age of 40-49 years. This is 
in line with the few studies using jumping mechanography for 
the analysis of muscle power. Due to the lack of longitudinal 
studies using jumping mechanography, the results can 
only be compared with cross-sectional studies or with 
studies using other power assessment methods. Runge 
et al. identified, in a cross-sectional analysis with a wide 
range of ages of subjects between 18-88 years, that 2LJP 
showed an earlier and stronger decline with age compared 
to CRTP5. They concluded that jumping mechanography and 
the evaluation of muscle power are more sensitive for age-
related decline than the evaluation of CRTP, muscle mass 
or muscle strength. Siglinsky et al. showed in their cross-
sectional study that muscle power during countermovement 
jumps on a Leonardo Mechanograph® is more strongly 
correlated with age than grip strength or time for the chair 
rise test34. Dietzel et al. reported the cross-sectional results 
of the baseline evaluation of this study26. The cross-sectional 
as well as the current longitudinal analysis showed that 2LJP 
declines earlier than CRTP in both women and men26. In the 
cross-sectional analysis the group differences compared 
to a reference group evaluated by Dunnett’s test became 
significant earlier than in the longitudinal analysis. One 
main difference was the definition of the reference groups. 
The reference group of the baseline study by Dietzel et al. 
consists of people aged 20-29 years and thus includes one 
decade less than the current study. This was caused by the 
large drop-out rate in the youngest age group at the follow-
up. To include homogeneously balanced sample sizes by age 
group in the analysis, the two youngest age groups have 
been collated. This may have led to different results in the 
comparisons between the groups.
There are further cross-sectional35-37 and longitudinal 
studies1,38, which focused on the differences between 
muscle power and muscle strength or mass with age, but 
used different assessment instruments compared to this 
study. They all support the observation of this study that 
muscle power declined earlier and more extensively than 
other muscle parameters in women and in men. However, 
they need to be interpreted with caution due to the different 
study designs.
In this study, both, 2LJP and CRTP, showed in the oldest age 
group a significantly higher reduction compared to variables 
of body composition and muscle strength. The decline of 
muscle power for the age group of 70+ in the present study 
ranges between -1.84% and -3.5% per year, depending 
on the assessment and sex. Similar rates of decline were 
also reported by Skelton et al37. They observed in a cross-
sectional study for a sample of 65 to 89 years old an age-
related decline of 3% per year for men and 1.7% per year 
for women for muscle power of leg extention37. A longitudinal 
study of Reid et al. revealed a decline of muscle power of 
2.9% per year for subjects aged 70-85 years1. While the 
annual decline of the cross-sectional study by Skelton et al. 
should be carefully compared with the results of the present 
longitudinal study, the results of Reid et al. are comparable 
in its extent with the results of this study. The research team 
of Reid investigated muscle power in a 3-year longitudinal 
analysis using a bilateral leg press apparatus1. They identified 
that the healthy subjects maintained their muscle strength at 
follow-up while muscle power showed significant reductions. 
Additionally, Reid et al. measured neuromuscular activation 
of vastus lateralis by surface electromyography (EMG), which 
also showed a significant reduction in healthy subjects. They 
concluded that early decline of neuromuscular activation is 
associated with impairments in contraction velocity and thus 
in muscle power1. 
Further, a study of van Roie and team found out that the 
velocity component of peak power tended to decline more in 
women than in men35. They concluded that the decline in the 
velocity component of muscle power may be more relevant 
in women35, which is in line with present findings that the 
deterioration process of muscle power tested by 2LJ, having 
a higher explosive power component than CRT, begins earlier 
in women than men and the differences in the age groups are 
much clearer and significant. 
The influence of the velocity component of muscle 
power, notably during two-leg jumps, as a leading factor 
in the deterioration process was investigated by several 
biomechanical studies. As muscle power is the product of 
force and velocity, the large decrease seems to be due to 
an early loss of the largest and fastest contracting type II 
muscle fibres39. Due to a general demyelination of the central 
and peripheral nervous system and the dominance of type 
I muscle fibres, the axonal conduction velocity slows down 
with age. This observation was made for both men and 
women40,41. The only sex-specific difference was the smaller 
and decreasing size of type II muscle fibres in women than 
in men with increasing age41,42. Further intrinsic changes in 
actin-myosin structures, motor units and as well in hormones 
and metabolism contribute to reduced muscle power, which 
might explain the earlier loss in women than in men in this 
study9,43,44. Further this can be one of the reasons, why 
women have a higher risk of falls and fall-related injuries45. 
As a larger eccentric load is expected during the lift off in 
2LJ than in CRT, one reason for the earlier reduction seems 
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to be due to changes in tendon stiffness and composition as 
Narici et al. stated46. Although the effect of ageing on tendon 
structures has not been fully and systematically investigated, 
they concluded that more flexible tendons need more time to 
transmit fast forces from muscles to bones. They reported 
that older tendons were 15% more flexible than younger 
tendons46. Therefore, fast eccentric activation of the elastic 
elements of older people occurs with greater difficulty 
and thus is a crucial indicator for motor disorders in older 
adults11. In women, the influence of estrogen on tendons 
seems to play a crucial role in muscle performance. There 
is conflicting evidence on how the hormone estrogen affects 
tendon stiffness in postmenopausal women, but it should be 
considered as a factor for the earlier loss of muscle power 
compared to men in this study47. 
The present study revealed promising results for the 
assessment of muscle power using muscle mechanography. 
The results of the current study imply that not muscle 
strength or mass, but rather muscle power, shows earlier and 
pronounced decline and might be a more relevant parameter 
for the identification of sarcopenic changes. In a clinical 
pathway published by the EWGSOP, they recommend first 
assessing muscle strength by handgrip strength or CRT to 
decide if sarcopenia is possible followed by the evaluation of 
muscle mass to confirm sarcopenia, and finally the evaluation 
of the severity by physical performance tests3. In agreement 
with other studies, the evaluation of muscle power as a 
parameter of physical performance should not be the last step 
in the clinical pathway to assess the severity of sarcopenia, but 
the first to identify early changes8,20,48. The question remains 
as to whether, if muscle power is such a valuable parameter 
in the diagnostic process, it has the same importance for the 
prevention and treatment of sarcopenia. Many activities in 
daily life depend on powerful movements such as climbing 
stairs, getting up off chairs or reacting to perturbations to 
prevent falling. As mentioned above, the extent of muscle 
power might predict the risk of falls and impairments more 
effectively than traditional measurements1,8,10,11. To develop a 
full picture of muscle power for the diagnosis of sarcopenia, 
additional longitudinal studies will be needed to investigate 
its predictive value for clinically relevant outcomes.
We consider the longitudinal design as a strength of our 
study. However, there have also been several limitations. One 
weakness is that we were only able to include two time points 
of assessments. This could have affected the assumption 
of linear changes for which contradictory evidence exists. 
There are studies reporting linear patterns5,29 and others 
curvilinear patterns24,35. Most of them confirm that power 
increases in young years, has a stable development between 
the ages of 20 and 40 years and then declines continuously 
over age26,35. Unfortunately, there is a lack of prospective 
studies which examine this age-related decline of muscle 
power with mechanography. Therefore, caution must be 
applied when comparing the current results with studies 
using a cross-sectional design or reporting rates of decline 
over the entire range of age, because this design can result 
in an overestimation of the decline in young years or an 
underestimation in the oldest age groups. 
Particularly in longitudinal studies with more than one 
test session and different raters, an uncontrolled factor is 
the possibility of low inter-rater and intersession reliability 
of the measurement method. Several studies confirmed the 
reproducibility of jumping mechanography and the chair 
rise test20-23,49. To increase the reliability of this study, a 
standardised test protocol was used, and the examinations 
were carried out by the same evaluator of the baseline 
investigation. 
We have only focused on healthy subjects and thus the 
normal aging process. If muscle power is to be included in 
the assessment of sarcopenia, cut-off values are required. It 
would have been of great interest to examine a large cohort 
with healthy and mobility-limited subjects to define cut-off 
points for sarcopenia diagnosis and to analyse the predictive 
value for clinical endpoints. An initial data exploration with 
a subset of the baseline cohort by Dietzel et al.8 showed 
an association between muscular power assessed by 
mechanography and sarcopenia, falls and impairments in the 
activities of daily living. However, as the focus in sampling 
was put on healthy subjects, there were too few subjects in 
the cohort who were classified as sarcopenic according to the 
current definitions to provide generalised conclusions. So, 
defining cut-off points was not included in the scope of this 
study and should be explored in further research. 
There are few studies that investigate muscle function 
using muscle mechanography, notably longitudinal 
studies18,20,25,34,50,51. For this reason, our results have to 
be compared with cross-sectional or longitudinal studies 
measuring muscle power by other assessment methods. This 
limitation must be taken into account when interpreting the 
results. To develop a full picture and comparable data of the 
assessment of muscle power by muscle mechanography, 
additional studies are required. 
A limitation in the scope of the sample is the loss to follow-
up rate of 53.5%. This high proportion of subjects lost to 
follow-up has certainly resulted in a bias in the results. In 
Table 1 the participants who dropped out are compared with 
those who returned to follow-up. One point to consider in 
the analyses is that men participating in the follow-up were 
significantly older at baseline (p<0.01) and had a higher 
weight and BMI. As mentioned above, this might have affected 
all measurements where the influence of anthropometric 
values has been demonstrated (i.e. ASM/BMI, ASM/h2, 
grip strength)3,52. However, for the power assessments it 
is important to know that the Leonardo Mechanograph® 
assesses the body-weight corrected power [W/kg], so that 
the results for CRTP and 2LJP cannot be affected by that 
difference4. 
Further the high drop-out rate can cause an 
overestimation or an underestimation of the outcome 
variables. As mentioned above the drop out resulted in an 
under-sampling of the youngest and oldest age group. We 
have managed this by structuring the baseline and follow-
up sample size per age-group relatively homogeneously 
and used only complete data sets.
23http://www.ismni.org
S. Wiegmann et al.: Longitudinal changes in muscle power compared to muscle strength and mass
The use of two different devices for dual-energy X-Ray 
absorptiometer can be problematic. A study by Watson et 
al.53 has shown significant differences in the measurement of 
iDXA and Prodigy, in particular for bone mineral content and 
fat mass when comparing absolute values. Minor differences 
were found for lean mass estimates of arms and legs53. In the 
current study, the same device was used for each subject 
at both timepoints and only the change between these two 
points in time were analysed. Therefore, sampling bias did 
not influence the results.
In conclusion, the results of this longitudinal study 
support the observation that the three indicators of 
sarcopenia muscle mass, muscle strength and physical 
performance, i.e. muscle power, show different reduction 
rates depending on age and sex. Muscle power assessed 
by two-leg jumps is the one with the earliest and highest 
rate of loss. Changes in muscle strength becomes obvious 
later in women from the age of 50 years and in men at the 
age of 70+ years. This indicates that the assessment of 
handgrip strength which is commonly and primarily used 
as a pre-screening tool regarding early sarcopenia should 
be supported by the evaluation of muscle power. 
Taken together, the findings of our study support strong 
recommendations for measuring muscle power in the 
diagnostic process of sarcopenia. Muscle mechanography 
can be established as a useful tool in clinical practice, is easy 
to use and is associated with moderate equipment costs 
compared to iDXA or other technical devices. 
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